For patients with end-stage renal disease (ESRD), those with concomitant psoriasis are younger and more often have cancer, diabetes mellitus, and coronary artery disease, according to a study published online July 26 in the ...
Aug 18, 2022
0
6
An international group of researchers investigated why mutations often associated with renal cancer result specifically in renal cancer, instead of other cancer types.
Aug 9, 2022
0
85
Kidney cancer accounts for only 4% of all cancers in the United States; however, its incidence has more than doubled since 1975, with the most common type being clear cell renal cell carcinoma. While outcomes of patients ...
Jul 8, 2022
0
60
In what is believed to be the first study of its kind, new UVA Health research reveals that a factory-calibrated continuous glucose monitor (CGM) may be sufficiently accurate for use by people on dialysis, a group often plagued ...
Jun 29, 2022
0
10
Chromophobe renal cell carcinoma (ChRCC) is a rare form of kidney cancer for which there are currently no proven treatments for metastatic or unresectable disease.
Jun 20, 2022
0
77
An exploratory analysis of data from the SURPASS-4 trial has shown that adults with type 2 diabetes and increased cardiovascular risk receiving tirzepatide experience fewer renal complications, especially new onset of macroalbuminuria; ...
Jun 6, 2022
0
7
By filtering waste products and toxins from the urine, the kidney is one of the most important players in human metabolism. It is estimated that several million patients worldwide die each year from renal disease. When a ...
Jun 3, 2022
0
3
Rapid post-dialysis recovery time (DRT) occurs in most end-stage renal disease (ESRD) patients receiving five dialysis treatments each week in a skilled nursing facility (SNF) setting, according to a study published online ...
May 13, 2022
0
3
A team of researchers from Germany, the U.S. and Japan has found via a three-year trial that the SPYRAL HTN-ON MED renal denervation procedure reduced the blood pressure of volunteers in the trial. In their paper published ...
For patients with moderate- to end-stage chronic kidney disease, elobixibat is associated with improvement in constipation and lipid metabolism, according to a study recently published in Frontiers in Medicine.
Mar 21, 2022
0
12
